Insider Trading & Ownership of Bain Capital Life Sciences Investors, LLC

Location
Boston, MA
Summary
The estimated value of insider holdings of Bain Capital Life Sciences Investors, LLC is at least $838,879,258 dollars as of 06 Feb 2026. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Heartflow, Inc. and owns shares of Heartflow, Inc. (HTFL) stock worth about $293.07M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $239M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. stock worth about $200.69M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $46.25M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $24.76M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Annexon, Inc. and owns shares of Annexon, Inc. (ANNX) stock worth about $24.43M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of RAPID MICRO BIOSYSTEMS, INC. and owns shares of RAPID MICRO BIOSYSTEMS, INC. (RPID) stock worth about $8.35M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $2.33M.
Signature
See signatures included in Exhibit 99.1
All Insider Reports
All Insider Reports

Notify me when Bain Capital Life Sciences Investors, LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Bain Capital Life Sciences Investors, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HTFL Heartflow, Inc. 10%+ Owner $293,070,831 -$56,100,000 -16% 04 Feb 2026
NAMS, NAMSW NewAmsterdam Pharma Co N.V. 10%+ Owner $239,004,182 13 Dec 2024
SWTX SpringWorks Therapeutics, Inc. 10%+ Owner $200,690,112 10 Aug 2021
SLDB Solid Biosciences Inc. 10%+ Owner $46,252,926 19 Feb 2025
OLMA Olema Pharmaceuticals, Inc. 10%+ Owner $24,758,970 08 Jan 2025
ANNX Annexon, Inc. 10%+ Owner $24,428,590 25 May 2023
RPID RAPID MICRO BIOSYSTEMS, INC. 10%+ Owner $8,345,154 19 Jul 2021
XLO Xilio Therapeutics, Inc. 10%+ Owner $2,328,493 08 Dec 2021
KYTX Kyverna Therapeutics, Inc. 10%+ Owner 12 Feb 2024

Insider Transactions Reported by Bain Capital Life Sciences Investors, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.